152 related articles for article (PubMed ID: 28192162)
1. Transcriptional regulation of RACK1 and modulation of its expression: Role of steroid hormones and significance in health and aging.
Buoso E; Galasso M; Serafini MM; Ronfani M; Lanni C; Corsini E; Racchi M
Cell Signal; 2017 Jul; 35():264-271. PubMed ID: 28192162
[TBL] [Abstract][Full Text] [Related]
2. Role of Hormones in the Regulation of RACK1 Expression as a Signaling Checkpoint in Immunosenescence.
Racchi M; Buoso E; Ronfani M; Serafini MM; Galasso M; Lanni C; Corsini E
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28684670
[TBL] [Abstract][Full Text] [Related]
3. Functional mapping of the promoter region of the GNB2L1 human gene coding for RACK1 scaffold protein.
Del Vecchio I; Zuccotti A; Pisano F; Canneva F; Lenzken SC; Rousset F; Corsini E; Govoni S; Racchi M
Gene; 2009 Feb; 430(1-2):17-29. PubMed ID: 19000751
[TBL] [Abstract][Full Text] [Related]
4. Effect of estrogen-active compounds on the expression of RACK1 and immunological implications.
Buoso E; Masi M; Galbiati V; Maddalon A; Iulini M; Kenda M; Sollner Dolenc M; Marinovich M; Racchi M; Corsini E
Arch Toxicol; 2020 Jun; 94(6):2081-2095. PubMed ID: 32328699
[TBL] [Abstract][Full Text] [Related]
5. The cyclic AMP phosphodiesterase 4D5 (PDE4D5)/receptor for activated C-kinase 1 (RACK1) signalling complex as a sensor of the extracellular nano-environment.
Yarwood SJ; Parnell E; Bird RJ
Cell Signal; 2017 Jul; 35():282-289. PubMed ID: 28069443
[TBL] [Abstract][Full Text] [Related]
6. The scaffold protein RACK1 is a target of endocrine disrupting chemicals (EDCs) with important implication in immunity.
Buoso E; Galasso M; Ronfani M; Papale A; Galbiati V; Eberini I; Marinovich M; Racchi M; Corsini E
Toxicol Appl Pharmacol; 2017 Jun; 325():37-47. PubMed ID: 28412309
[TBL] [Abstract][Full Text] [Related]
7. Structural analysis of ribosomal RACK1 and its role in translational control.
Nielsen MH; Flygaard RK; Jenner LB
Cell Signal; 2017 Jul; 35():272-281. PubMed ID: 28161490
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the Mineralocorticoid Receptor With RACK1 and Its Role in Aldosterone Signaling.
Kuppusamy M; Gomez-Sanchez EP; Beloate LN; Plonczynski M; Naray-Fejes-Toth A; Fejes-Toth G; Gomez-Sanchez CE
Endocrinology; 2017 Jul; 158(7):2367-2375. PubMed ID: 28472300
[TBL] [Abstract][Full Text] [Related]
9. Roles for RACK1 in cancer cell migration and invasion.
Duff D; Long A
Cell Signal; 2017 Jul; 35():250-255. PubMed ID: 28336233
[TBL] [Abstract][Full Text] [Related]
10. Effects of endocrine disrupting chemicals on the expression of RACK1 and LPS-induced THP-1 cell activation.
Masi M; Maddalon A; Iulini M; Linciano P; Galbiati V; Marinovich M; Racchi M; Corsini E; Buoso E
Toxicology; 2022 Oct; 480():153321. PubMed ID: 36113621
[TBL] [Abstract][Full Text] [Related]
11. Cortisol-induced SRSF3 expression promotes GR splicing, RACK1 expression and breast cancer cells migration.
Buoso E; Ronfani M; Galasso M; Ventura D; Corsini E; Racchi M
Pharmacol Res; 2019 May; 143():17-26. PubMed ID: 30862604
[TBL] [Abstract][Full Text] [Related]
12. Activation of the cAMP Pathway Induces RACK1-Dependent Binding of β-Actin to BDNF Promoter.
Neasta J; Fiorenza A; He DY; Phamluong K; Kiely PA; Ron D
PLoS One; 2016; 11(8):e0160948. PubMed ID: 27505161
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of BDNF expression via the scaffolding protein RACK1.
He DY; Neasta J; Ron D
J Biol Chem; 2010 Jun; 285(25):19043-50. PubMed ID: 20410295
[TBL] [Abstract][Full Text] [Related]
14. RACK1 promotes lung cancer cell growth via an MCM7/RACK1/ Akt signaling complex.
Fei L; Ma Y; Zhang M; Liu X; Luo Y; Wang C; Zhang H; Zhang W; Han Y
Oncotarget; 2017 Jun; 8(25):40501-40513. PubMed ID: 28465488
[TBL] [Abstract][Full Text] [Related]
15. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D
Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482
[TBL] [Abstract][Full Text] [Related]
16. Endocrine-Disrupting Chemicals' (EDCs) Effects on Tumour Microenvironment and Cancer Progression: Emerging Contribution of RACK1.
Buoso E; Masi M; Racchi M; Corsini E
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287384
[TBL] [Abstract][Full Text] [Related]
17. Increased PKCα activity by Rack1 overexpression is responsible for chemotherapy resistance in T-cell acute lymphoblastic leukemia-derived cell line.
Lei J; Li Q; Gao Y; Zhao L; Liu Y
Sci Rep; 2016 Sep; 6():33717. PubMed ID: 27644318
[TBL] [Abstract][Full Text] [Related]
18. RACK1/TRAF2 regulation of modulator of apoptosis-1 (MOAP-1).
Law J; Kwek I; Svystun O; Lim J; Tan CT; Luong L; Yu VC; Baksh S
Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):684-694. PubMed ID: 29470995
[TBL] [Abstract][Full Text] [Related]
19. Receptor for activated C-kinase 1 regulates the cell surface expression and function of ATP binding cassette G2.
Ikebuchi Y; Ito K; Takada T; Anzai N; Kanai Y; Suzuki H
Drug Metab Dispos; 2010 Dec; 38(12):2320-8. PubMed ID: 20858845
[TBL] [Abstract][Full Text] [Related]
20. RACK1 stabilises the activity of PP2A to regulate the transformed phenotype in mammary epithelial cells.
Kiely M; Adams DR; Hayes SL; O'Connor R; Baillie GS; Kiely PA
Cell Signal; 2017 Jul; 35():290-300. PubMed ID: 27600565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
